Optimisation of cervical cancer screening programme by introducing genome detection of human papillomavirus using self-saving kits in women who do not participate in existing screening in the long term (Q66365)

From EU Knowledge Graph
Revision as of 00:08, 29 November 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr: translated_label)
Jump to navigation Jump to search
Project Q66365 in Czech Republic
Language Label Description Also known as
English
Optimisation of cervical cancer screening programme by introducing genome detection of human papillomavirus using self-saving kits in women who do not participate in existing screening in the long term
Project Q66365 in Czech Republic

    Statements

    0 references
    0 references
    9,404,358.31 Czech koruna
    0 references
    376,174.33 Euro
    10 January 2020
    0 references
    12,124,877.76 Czech koruna
    0 references
    484,995.11 Euro
    10 January 2020
    0 references
    77.56 percent
    0 references
    1 March 2018
    0 references
    28 February 2021
    0 references
    Ústav zdravotnických informací a statistiky ČR
    0 references
    0 references
    0 references

    50°4'3.86"N, 14°25'18.62"E
    0 references
    12800
    0 references
    Předložený projekt směřuje k praktickému ověření zdravotnické technologie založené na vědeckých důkazech, která má reálný potenciál zvýšit efektivitu (diagnostickou bezpečnost, kvalitu, účinnost, nákladovou efektivitu) programu screeningu karcinomu děložního hrdla, který je v ČR bohužel stále nezanedbatelnou příčinou úmrtí na nádorové choroby. V případě úspěšného ověření lze očekávat zvýšení kvality programu a zvětšení jeho potenciálního dopadu na snížení úmrtnosti pro karcinom děložního hrdla. (Czech)
    0 references
    The submitted project is aimed at practical verification of medical technology based on scientific evidence, which has real potential to increase efficiency (diagnostic safety, quality, efficiency, cost-effectiveness) of cervical cancer screening programme, which is unfortunately still a significant cause of cancer death in the Czech Republic. In the event of successful verification, an increase in the quality of the programme and an increase in its potential impact on cervical cancer reduction may be expected. (English)
    23 October 2020
    0 references

    Identifiers

    CZ.03.2.63/0.0/0.0/15_039/0008171
    0 references